Cancer Chemoprevention by Targeting the Epigenome

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|12|13|1925-1956

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.13, 2011-12, pp. : 1925-1956

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer

By  

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-05 ,pp. : 23-35

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer

By  

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-03 ,pp. : 23-35

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting epigenetic regulatory mechanisms in cancer chemoprevention

By Fay Judith R   Crowell James A   Kopelovich Levy  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 315-328

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Epigenome in Hematopoietic Malignancies

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 4, 2006-05 ,pp. : 242-252

Bentham Science Publishers

Access to resources Recommend Favorite

Roles of Prostanoids in Colon Carcinogenesis and their Potential Targeting for Cancer Chemoprevention

By  

Current Pharmaceutical Design, Vol. 12, Iss. 19, 2006-07 ,pp. : 2375-2382

Bentham Science Publishers

Access to resources Recommend Favorite